New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Over the past decade, several novel immunotherapies have transformed the treatment landscape of relapsed or refractory B-cell acute lymphoblastic leukaemia. In the pivotal TOWER trial, blinatumomab—a ...